Cogent Biosciences, Inc. (COGT)
30.38
-0.49
(-1.59%)
USD |
NASDAQ |
Oct 06, 16:00
30.38
0.00 (0.00%)
After-Hours: 20:00
Cogent Biosciences Market Cap : 5.214B for Oct. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 06, 2026 | 5.214B |
| October 05, 2026 | 5.299B |
| October 02, 2026 | 5.324B |
| October 01, 2026 | 5.422B |
| September 30, 2026 | 5.496B |
| September 29, 2026 | 5.434B |
| September 28, 2026 | 5.469B |
| September 25, 2026 | 5.546B |
| September 24, 2026 | 5.395B |
| September 23, 2026 | 5.391B |
| September 22, 2026 | 5.601B |
| September 21, 2026 | 5.493B |
| September 18, 2026 | 5.407B |
| September 17, 2026 | 5.697B |
| September 16, 2026 | 5.585B |
| September 15, 2026 | 5.620B |
| September 14, 2026 | 5.735B |
| September 11, 2026 | 5.735B |
| September 10, 2026 | 5.850B |
| September 09, 2026 | 5.867B |
| September 08, 2026 | 6.056B |
| September 04, 2026 | 5.966B |
| September 03, 2026 | 5.999B |
| September 02, 2026 | 5.934B |
| September 01, 2026 | 5.953B |
| Date | Value |
|---|---|
| August 31, 2026 | 6.007B |
| August 28, 2026 | 5.951B |
| August 27, 2026 | 6.366B |
| August 26, 2026 | 6.303B |
| August 25, 2026 | 6.316B |
| August 24, 2026 | 6.219B |
| August 21, 2026 | 6.304B |
| August 20, 2026 | 6.061B |
| August 19, 2026 | 6.325B |
| August 18, 2026 | 6.419B |
| August 17, 2026 | 6.500B |
| August 14, 2026 | 6.510B |
| August 13, 2026 | 6.404B |
| August 12, 2026 | 6.691B |
| August 11, 2026 | 6.643B |
| August 10, 2026 | 7.128B |
| August 07, 2026 | 7.276B |
| August 06, 2026 | 7.175B |
| August 05, 2026 | 7.220B |
| August 04, 2026 | 7.318B |
| August 03, 2026 | 6.638B |
| July 31, 2026 | 6.650B |
| July 30, 2026 | 7.065B |
| July 29, 2026 | 6.759B |
| July 28, 2026 | 6.947B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna, Inc. | 74.80B |
| Arrowhead Pharmaceuticals, Inc. | 8.685B |
| Oncolytics Biotech, Inc. | 74.53M |
| Sangamo Therapeutics, Inc. | 58.00M |
| Sarepta Therapeutics, Inc. | 1.828B |
Market Cap Related Metrics
| Price to Book Value | 11.15 |
| Price | 30.38 |
| Earnings Yield | -8.05% |